REPORT ID 15965

Global Antidiabetic Thiazolidinediones Market Professional Survey Report 2017

Publish Date
30-Nov-17
Pages
105
Format
Electronic (PDF)

This report studies Antidiabetic Thiazolidinediones in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Sanofi
    Takeda Pharmaceuticals
    Eli Lilly
    Merck & Co.
    Novo Nordisk
    Bristol-Myers Squibb
    Pfizer
    AstraZeneca
    GlaxoSmithKline
    Boehringer Ingelheim

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Rosiglitazone
    Pioglitazone

By Application, the market can be split into
    Hospitals
    Clinics
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Antidiabetic Thiazolidinediones Market Professional Survey Report 2017
1 Industry Overview of Antidiabetic Thiazolidinediones
    1.1 Definition and Specifications of Antidiabetic Thiazolidinediones
        1.1.1 Definition of Antidiabetic Thiazolidinediones
        1.1.2 Specifications of Antidiabetic Thiazolidinediones
    1.2 Classification of Antidiabetic Thiazolidinediones
        1.2.1 Rosiglitazone
        1.2.2 Pioglitazone
    1.3 Applications of Antidiabetic Thiazolidinediones
        1.3.1 Hospitals
        1.3.2 Clinics
        1.3.3 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Antidiabetic Thiazolidinediones
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Antidiabetic Thiazolidinediones
    2.3 Manufacturing Process Analysis of Antidiabetic Thiazolidinediones
    2.4 Industry Chain Structure of Antidiabetic Thiazolidinediones

3 Technical Data and Manufacturing Plants Analysis of Antidiabetic Thiazolidinediones
    3.1 Capacity and Commercial Production Date of Global Antidiabetic Thiazolidinediones Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Antidiabetic Thiazolidinediones Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Antidiabetic Thiazolidinediones Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Antidiabetic Thiazolidinediones Major Manufacturers in 2016

4 Global Antidiabetic Thiazolidinediones Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Antidiabetic Thiazolidinediones Capacity and Growth Rate Analysis
        4.2.2 2016 Antidiabetic Thiazolidinediones Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Antidiabetic Thiazolidinediones Sales and Growth Rate Analysis
        4.3.2 2016 Antidiabetic Thiazolidinediones Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Antidiabetic Thiazolidinediones Sales Price
        4.4.2 2016 Antidiabetic Thiazolidinediones Sales Price Analysis (Company Segment)

5 Antidiabetic Thiazolidinediones Regional Market Analysis
    5.1 North America Antidiabetic Thiazolidinediones Market Analysis
        5.1.1 North America Antidiabetic Thiazolidinediones Market Overview
        5.1.2 North America 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.1.4 North America 2016 Antidiabetic Thiazolidinediones Market Share Analysis
    5.2 China Antidiabetic Thiazolidinediones Market Analysis
        5.2.1 China Antidiabetic Thiazolidinediones Market Overview
        5.2.2 China 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.2.4 China 2016 Antidiabetic Thiazolidinediones Market Share Analysis
    5.3 Europe Antidiabetic Thiazolidinediones Market Analysis
        5.3.1 Europe Antidiabetic Thiazolidinediones Market Overview
        5.3.2 Europe 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.3.4 Europe 2016 Antidiabetic Thiazolidinediones Market Share Analysis
    5.4 Southeast Asia Antidiabetic Thiazolidinediones Market Analysis
        5.4.1 Southeast Asia Antidiabetic Thiazolidinediones Market Overview
        5.4.2 Southeast Asia 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.4.4 Southeast Asia 2016 Antidiabetic Thiazolidinediones Market Share Analysis
    5.5 Japan Antidiabetic Thiazolidinediones Market Analysis
        5.5.1 Japan Antidiabetic Thiazolidinediones Market Overview
        5.5.2 Japan 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.5.4 Japan 2016 Antidiabetic Thiazolidinediones Market Share Analysis
    5.6 India Antidiabetic Thiazolidinediones Market Analysis
        5.6.1 India Antidiabetic Thiazolidinediones Market Overview
        5.6.2 India 2012-2017E Antidiabetic Thiazolidinediones Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Antidiabetic Thiazolidinediones Sales Price Analysis
        5.6.4 India 2016 Antidiabetic Thiazolidinediones Market Share Analysis

6 Global 2012-2017E Antidiabetic Thiazolidinediones Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Antidiabetic Thiazolidinediones Sales by Type
    6.2 Different Types of Antidiabetic Thiazolidinediones Product Interview Price Analysis
    6.3 Different Types of Antidiabetic Thiazolidinediones Product Driving Factors Analysis
        6.3.1 Rosiglitazone of Antidiabetic Thiazolidinediones Growth Driving Factor Analysis
        6.3.2 Pioglitazone of Antidiabetic Thiazolidinediones Growth Driving Factor Analysis

7 Global 2012-2017E Antidiabetic Thiazolidinediones Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Antidiabetic Thiazolidinediones Consumption by Application
    7.2 Different Application of Antidiabetic Thiazolidinediones Product Interview Price Analysis
    7.3 Different Application of Antidiabetic Thiazolidinediones Product Driving Factors Analysis
        7.3.1 Hospitals of Antidiabetic Thiazolidinediones Growth Driving Factor Analysis
        7.3.2 Clinics of Antidiabetic Thiazolidinediones Growth Driving Factor Analysis
        7.3.3 Other of Antidiabetic Thiazolidinediones Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antidiabetic Thiazolidinediones
    8.1 Sanofi
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Sanofi 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Sanofi 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.2 Takeda Pharmaceuticals
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Takeda Pharmaceuticals 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Takeda Pharmaceuticals 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.3 Eli Lilly
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Eli Lilly 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Eli Lilly 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.4 Merck & Co.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Merck & Co. 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Merck & Co. 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.5 Novo Nordisk
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Novo Nordisk 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Novo Nordisk 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.6 Bristol-Myers Squibb
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Bristol-Myers Squibb 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bristol-Myers Squibb 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.7 Pfizer
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Pfizer 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Pfizer 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.8 AstraZeneca
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 AstraZeneca 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 AstraZeneca 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.9 GlaxoSmithKline
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 GlaxoSmithKline 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 GlaxoSmithKline 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis
    8.10 Boehringer Ingelheim
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Boehringer Ingelheim 2016 Antidiabetic Thiazolidinediones Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Boehringer Ingelheim 2016 Antidiabetic Thiazolidinediones Business Region Distribution Analysis

9 Development Trend of Analysis of Antidiabetic Thiazolidinediones Market
    9.1 Global Antidiabetic Thiazolidinediones Market Trend Analysis
        9.1.1 Global 2017-2022 Antidiabetic Thiazolidinediones Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Antidiabetic Thiazolidinediones Sales Price Forecast
    9.2 Antidiabetic Thiazolidinediones Regional Market Trend
        9.2.1 North America 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
        9.2.2 China 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
        9.2.3 Europe 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
        9.2.5 Japan 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
        9.2.6 India 2017-2022 Antidiabetic Thiazolidinediones Consumption Forecast
    9.3 Antidiabetic Thiazolidinediones Market Trend (Product Type)
    9.4 Antidiabetic Thiazolidinediones Market Trend (Application)

10 Antidiabetic Thiazolidinediones Marketing Type Analysis
    10.1 Antidiabetic Thiazolidinediones Regional Marketing Type Analysis
    10.2 Antidiabetic Thiazolidinediones International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Antidiabetic Thiazolidinediones by Region
    10.4 Antidiabetic Thiazolidinediones Supply Chain Analysis

11 Consumers Analysis of Antidiabetic Thiazolidinediones
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Antidiabetic Thiazolidinediones Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source